Sridhar Sethuraman
Executive Director-finance, Head- Fp & a and Treasury @Revance
Signup · Get unlimited contacts
WORK HISTORY
Executive Director-finance, Head- Fp & a and Treasury @Revance
San Francisco, CA, US
1) Scaled FP & A team from pre-revenue R&D phase to Commercialization2) Finance lead on licensing and partnership deals3) Streamlines processes and models to support long range plans, annual plans and forecasts4) Drove discussions around Financing and participated / supported CFO on various financing options including Follow on, ATM, Convertible debt and Venture debt5) Led clinical trial benchmarking exercises in collaboration with Head of R & D6) Invested in FP & A technology and implemented dashboards
EDUCATION
IMA | Institute of Management Accountants
CMA, Certified Management Accountant
Hult International Business School
Executive MBA, Finance, Accounting, Management
Hult International Business School
Executive MBA
Institute of Cost Accountants of India
Certification, Financial Management, Accounting and Analysis
Hult International Business School
EMBA
University of Madras
Bachelorâs Degree, Commerce, Economics and Financial Accounting
SKILLS
ABOUT SRIDHAR SETHURAMAN
Experienced Finance Executive in the Specialty Pharma / Biotech / Medical Devices industry with broad Finance and Operations expertise across multiple areas. Proven track record of delivering results across multiple functional areas with a focus on achieving corporate goals. Have a strategic mindset, developed strategic scenarios and evaluated Business Development deals across US and International markets. Concepts that drive my thinking are: Economics, Cash Flow and Shareholder value. Drove cost optimization and cash preservation efforts throughout my career. Experience in mid size Pharma and Biotech including scaling from R&D to Commercial, leading Finance function in International markets (Revenue $20M-$150M) and FP & A in the US (Revenue:$200M-$7B) and pre-revenue Biotech. Developed and mentored high performing teams. Additional areas of expertise:FP & A: Strategic Planning, Budgeting, Forecasting, Close and Reporting across Clinical / R&D, Commercial and Corporate Finance at Revance Therapeutics, Inc and Allergan,Inc. Financing / Fund raising: Participated and Supported follow on Equity raise, ATM, Convertible Debt and Venture Debt of ~$900M. M&A: Developing models, Board presentations, Engaging with Advisors and Bankers, Due diligenceTreasury: Investment ManagementHeaded Finance teams in international markets including Japan, South Korea, India & South East Asia. Business Unit Controller- US Neurosciences, US Medical Dermatology, Managed Care CMO negotiationsEngagement with Executive Committee, Finance Committee and Board of Directors Financial Accounting, SOX/ internal controls and Audits Led quarter close process and met/ exceeded quarterly EPS guidance / targets for 28 consecutive quarters at Allergan,Inc.Education: Bachelors degree in Accounting, MBA from Hult International Business School, Boston and CMA from US and India.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.